Now part of Astellas Pharma
Iveric Bio (ivericbio.com) scores 49 out of 100 on Brand Analyzer, placing it in the Early Stage tier among Healthcare brands, in the 1st percentile of 16718 Healthcare brands.
Iveric Bio is a biopharmaceutical company headquartered in New York City, founded in 2007, that focused on developing treatments for retinal diseases. The company is now part of Astellas Pharma Inc., a global pharmaceutical corporation. Its website redirects visitors to the Astellas homepage, reflecting this integration. Iveric Bio's work targets patients with retinal conditions, healthcare providers, and the broader medical research community, combining specialized ophthalmology research with Astellas's larger pharmaceutical resources and global reach.
| Brand Name | Iveric Bio |
|---|---|
| Domain | ivericbio.com |
| Industry | Healthcare |
| Founded | 2007 |
| Headquarters | New York City |
| Parent Company / Owner | Astellas Pharma Inc. |
| Main Competitors | Apellis Pharmaceuticals (79/100), Regeneron Pharmaceuticals (92/100), Genentech (Roche) (84/100), Novartis (71/100), Bayer (82/100), Alcon (89/100) |
Moz Domain Authority 38/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Iveric Bio is now part of Astellas Pharma Inc. You will be automatically forwarded to the Astellas Homepage in 10 seconds." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram; no detected presence on X (Twitter), Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Iveric Bio?", Claude could identify the brand as of October 2026. Iveric Bio was a biopharmaceutical company focused on developing treatments for genetic and degenerative eye diseases, most notably geographic atrophy secondary to age-related macular degeneration. Its lead drug, avacincaptad pegol (marketed as Izervay), received FDA approval in Best known for Developing avacincaptad pegol (Izervay), an FDA-approved treatment for geographic atrophy, and being acquired by Astellas Pharma.
When asked "Best brands similar to Iveric Bio?", Claude would recommend Iveric Bio as of October 2026. It's a notable and recent example in the ophthalmology/retinal disease treatment space, especially relevant given its high-profile FDA approval and acquisition.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Iveric Bio's main competitors in Healthcare: Apellis Pharmaceuticals (79/100), Regeneron Pharmaceuticals (92/100), Genentech (Roche) (84/100), Novartis (71/100), Bayer (82/100).
Sources: Brand Analyzer scan
Iveric Bio has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 19, recommendation 30). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Iveric Bio official site
Iveric Bio was founded in 2007. Iveric Bio operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Iveric Bio is headquartered in New York City. Iveric Bio operates in the Healthcare category.
Sources: Wikidata
Iveric Bio scores 30/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Iveric Bio official site
Iveric Bio is a biopharmaceutical company headquartered in New York City that was founded in 2007 and specialized in developing treatments for retinal diseases. It is now part of Astellas Pharma Inc., a major global pharmaceutical company, following its acquisition and integration into Astellas's healthcare portfolio.
Sources: Iveric Bio official site
Iveric Bio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Iveric Bio official site
Iveric Bio worked on advancing treatments for retinal diseases as a biopharmaceutical company. Since becoming part of Astellas Pharma Inc., its research and operations have been integrated into Astellas's broader pharmaceutical business, combining specialized ophthalmology expertise with the resources and global reach of a major healthcare company.
Sources: Iveric Bio official site
Iveric Bio's work is intended for patients with retinal diseases, healthcare providers who treat such conditions, and the broader pharmaceutical and medical research community involved in developing and administering retinal disease treatments.
Sources: Iveric Bio official site
Iveric Bio scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Iveric Bio has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (30/100) and its weakest is trust (19/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 38/100 and thin schema.org structured data. In a live check, Claude could already identify Iveric Bio from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Iveric Bio: Intelligent DX (49/100), InjuryFinance (49/100), キッセイ薬品工業株式会社 (Kissei Pharmaceutical Co., Ltd.) (49/100), Mahindra Foundation (49/100).
A step up - brands to learn from: Word of Mouth Technology (56/100), Werskincare (56/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.